David Alfego

475 total citations
18 papers, 255 citations indexed

About

David Alfego is a scholar working on Infectious Diseases, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Alfego has authored 18 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Alfego's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and SARS-CoV-2 detection and testing (3 papers). David Alfego is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and SARS-CoV-2 detection and testing (3 papers). David Alfego collaborates with scholars based in United States, Russia and United Kingdom. David Alfego's co-authors include Stanley Letovsky, M. J. T. Lewis, Ajay Grover, Barbara S. Gillespie, Brian Poirier, Jennifer Ennis, Elizabeth Montgomery, Silvia Ferrè, Joseph A. Vassalotti and Jonathan Williams and has published in prestigious journals such as PLoS ONE, Biomaterials and Diabetes Care.

In The Last Decade

David Alfego

16 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Alfego United States	8	76	40	37	32	28	18	255
Sujeet Jha India	11	26 0.3×	86 2.1×	28 0.8×	49 1.5×	66 2.4×	25	290
Kulachanya Suwanwongse United States	8	195 2.6×	22 0.6×	14 0.4×	95 3.0×	36 1.3×	19	366
Yasemin Taşçı Yıldız Türkiye	12	30 0.4×	18 0.5×	16 0.4×	83 2.6×	129 4.6×	32	355
Xingji Lian China	7	52 0.7×	10 0.3×	44 1.2×	19 0.6×	5 0.2×	25	182
Sundus Sardar Qatar	9	109 1.4×	25 0.6×	9 0.2×	27 0.8×	4 0.1×	41	270
Anastasios Panagopoulos United States	6	55 0.7×	10 0.3×	3 0.1×	45 1.4×	13 0.5×	15	212
Camelia Elena Berghea Romania	8	38 0.5×	19 0.5×	5 0.1×	26 0.8×	42 1.5×	23	171
Joanne Michelle D. Gomez United States	7	77 1.0×	13 0.3×	3 0.1×	18 0.6×	8 0.3×	23	234
Salah Eddine Oussama Kacimi Algeria	7	108 1.4×	4 0.1×	6 0.2×	25 0.8×	14 0.5×	18	280
Shelief Y. Robbins-Juarez United States	4	300 3.9×	5 0.1×	118 3.2×	98 3.1×	37 1.3×	8	418

Countries citing papers authored by David Alfego

Since Specialization

Citations

This map shows the geographic impact of David Alfego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Alfego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Alfego more than expected).

Fields of papers citing papers by David Alfego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Alfego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Alfego. The network helps show where David Alfego may publish in the future.

Co-authorship network of co-authors of David Alfego

This figure shows the co-authorship network connecting the top 25 collaborators of David Alfego. A scholar is included among the top collaborators of David Alfego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Alfego. David Alfego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Fleming, James K., et al.. (2025). A strategy to increase identification of patients with Familial Hypercholesterolemia: Application of the Simon Broome lipid criteria in a large-scale retrospective analysis. American Journal of Preventive Cardiology. 21. 100930–100930.

Alfego, David, Alfonso C. Hernandez‐Romieu, Melissa Briggs‐Hagen, et al.. (2024). Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024. MMWR Morbidity and Mortality Weekly Report. 73(47). 1076–1081. 8 indexed citations

Alfego, David, et al.. (2023). 2686. High HIV and STI Rates in Patients with MPOX Identified in a Large National Database. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Lee, Min Kyung, David Alfego, & Suzanne E. Dale. (2023). Prevalence and trends in mono- and co-infection of COVID-19, influenza A/B, and respiratory syncytial virus, January 2018–June 2023. Frontiers in Public Health. 11. 1297981–1297981. 3 indexed citations

Alfego, David, et al.. (2023). Antibody titer levels and the effect on subsequent SARS-CoV-2 infection in a large US-based cohort. Heliyon. 9(2). e13103–e13103. 5 indexed citations

Alfego, David, Brian Poirier, Jonathan Williams, et al.. (2021). A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States. EClinicalMedicine. 36. 100902–100902. 63 indexed citations

Alfego, David, et al.. (2021). Follow-Up SARS-CoV-2 PCR Testing Outcomes From a Large Reference Lab in the US. Frontiers in Public Health. 9. 679012–679012. 1 indexed citations

Alfego, David, et al.. (2021). Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis. PLoS ONE. 16(4). e0250036–e0250036. 5 indexed citations

Alfego, David, Jennifer Ennis, Barbara S. Gillespie, et al.. (2021). Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database. Diabetes Care. 44(9). 2025–2032. 69 indexed citations

10.

Alfego, David, et al.. (2021). Association between attendance at an American diabetes camp and improvements in glycaemic control and treatment satisfaction. Endocrinology Diabetes & Metabolism. 4(3). e00254–e00254. 1 indexed citations

11.

Alfego, David, et al.. (2020). Treatment of Facial Fractures at a Level 1 Trauma Center: Do Medicaid and Non-Medicaid Enrollees Receive the Same Care?. Journal of Surgical Research. 252. 183–191. 8 indexed citations

12.

Rojas-Rodriguez, Raziel, Tiffany DeSouza, David Alfego, et al.. (2020). PAPPA-mediated adipose tissue remodeling mitigates insulin resistance and protects against gestational diabetes in mice and humans. Science Translational Medicine. 12(571). 35 indexed citations

13.

Alfego, David, et al.. (2019). Treatment of Acute Cholecystitis: Do Medicaid and Non-Medicaid Enrolled Patients Receive the Same Care?. Journal of Gastrointestinal Surgery. 24(4). 939–948. 5 indexed citations

14.

Alfego, David, et al.. (2019). Treatment of appendicitis: Do Medicaid and non-Medicaid–enrolled patients receive the same care?. Surgery. 166(5). 793–799. 4 indexed citations

15.

Alfego, David, Ulrich Rodeck, & Andres Kriete. (2018). Global mapping of transcription factor motifs in human aging. PLoS ONE. 13(1). e0190457–e0190457. 11 indexed citations

16.

Alfego, David & Andres Kriete. (2017). Simulation of Cellular Energy Restriction in Quiescence (ERiQ)—A Theoretical Model for Aging. Biology. 6(4). 44–44. 2 indexed citations

17.

Kriete, Andres, et al.. (2016). Distinct Cell Stress Responses Induced by ATP Restriction in Quiescent Human Fibroblasts. Frontiers in Genetics. 7. 171–171. 12 indexed citations

18.

Alfego, David, et al.. (2016). Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential. Biomaterials. 103. 197–206. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact